Valeant Libido Drug Sales Claims Cut In Half
Two of four counts will go forward in a stockholder suit accusing Valeant Pharmaceuticals International Inc. of bungling the marketing of a merger partner's potential breakthrough female libido drug, a Delaware...To view the full article, register now.
Already a subscriber? Click here to view full article